Implementation of Noninvasive Preimplantation Genetic Testing for Aneuploidy with Spent Blastocyst Medium into Clinical and Laboratory Practice: The First Successful Experience in Taiwan

Noninvasive preimplantation genetic testing for aneuploidy (niPGT-A) using cell-free DNA (cfDNA) present in the spent blastocyst medium (SBM) of human blastocysts has emerged as an alternative for classical preimplantation genetic testing for aneuploidy (PGT-A). The major benefit is to avoid possible damage to the trophectoderm and subsequently increase the implantation potential of the embryo. niPGT-A provides more information including the ploidy state of both trophectoderm and inner cell mass compared to invasive PGT-A in which only a few trophectoderm cells are assessed. This study was to report our first successful experience solely using niPGT-A to select embryos to transfer resulting in a successful delivery. This practical application is believed to be the first case report in Taiwan and can serve as an innovative model for other clinics to apply niPGT-A.